As a result, GLP-1 analogues are now positioned not only as diabetes drugs but also as cornerstone therapies in modern obesity care, drawing in new patient segments
Patients with type 1 diabetes depend on insulin for life support and also need insulin to control hyperglycemia and reduce the risk of diabetic complications
Regardless of medication type, the emphasis is on gradual, safe, and sustainable weight loss rather than rapid or extreme changes
PYY (Peptide YY) : PYY is a satiety hormone produced by L cells in the intestines, which, similar to GLP-1, increases in concentration after meals and can reduce food intake, thereby potentially aiding in combating obesity
SUGGESTED USE: For the most effective results, we recommend mixing one (1) scoop with 8-12 oz
You will likely notice reduced appetite suppression compared to your peak tirzepatide effect, particularly during weeks two through four after switching